It is a LIE to claim that this deal is worth only 24
It is a LIE to claim that this deal is worth only 24 million. That does not include the upfront payment (which the CEO has verified in his letter to shareholders is an ADDITIONAL amount), and it does not include the value of the PARTNER footing the bill for the entire clinical trial cost, and the eventual manufacturing, packaging, and marketing of the product.
Lies are a TOS violation. I hope any moderator who spots a lying post will delete it immediately.
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
GMS Enhances Human Resource Services with New Software Group Management Services (GMS) is proud to announce a significant advancement in their operations through the transition to GMS Connect, a progressive Human Resources Information System (HRIS) platform powered by PRO Software. This upgrade is not just a change; it represents a new era where efficiency meets security,...
Continue Reading
Gary Black's Insights on Tesla Sales Potential Managing director of Future Fund LLC, Gary Black, has expressed optimism about the future sales of Tesla Inc. (NASDAQ: TSLA). He suggests that a significant increase in sales for Tesla's Model 3 and Model Y could occur if the company addresses a crucial aspect of CEO Elon Musk's strategic plans. His insights have raised...
Continue Reading
Yandex's Innovative AI Solution in Infant Diagnostics Yandex has made significant strides in the realm of pediatric healthcare with its revolutionary AI technology designed to enhance brain development assessments in infants. This groundbreaking tool is the world's first of its kind, aiming to detect signs of cerebral palsy and other central nervous system disorders with...
Continue Reading
Exco Technologies Limited Prepares for Third Quarter Results Exco Technologies Limited (TSX – XTC) is gearing up to share its financial outcomes for the third quarter that concluded on June 30. The results will be officially announced following the conclusion of business on Wednesday, July 30. Conference Call Details for Investors Management at Exco invites all...
Continue Reading
Advocus Expands Leadership Team to Secure Future Directions Advocus, a title insurance underwriter based in Chicago, is cementing its legacy by announcing vital leadership appointments to mark its 60-year anniversary. These strategic moves are essential for steering the organization into a prosperous future while maintaining its core mission of supporting attorneys in...
Continue Reading
